Drug intelligence / Profile preview

crocetin

Development stage
Unknown
Lead developer
CervoMed
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**Crocetin** is a natural apocarotenoid dicarboxylic acid derived primarily from the flowers of saffron (Crocus sativus) and Gardenia jasminoides. Chemically, it is a carotenoid derivative with the formula C20H24O4, consisting of a polyene chain and two carboxylic acid groups. Crocetin exists as the aglycone (non-sugar) component of crocin, the principal pigment of saffron. Traditionally used in herbal medicine, crocetin has attracted modern research interest for its **antioxidant, anti-inflammatory, neuroprotective, cardioprotective, anticancer, atherosclerotic, antidiabetic, memory-enhancing, and antiviral** properties. It acts mainly by inhibiting nucleic acid synthesis, influencing oxidative stress pathways, inducing apoptosis, and modulating gene expression related to inflammatory, cell growth, and atherogenic processes. Additionally, crocetin has been studied for its ability to enhance oxygen diffusivity in hypoxic tissues, potentially benefiting conditions like hemorrhagic shock and ischemic injury. Its pharmacological activities may involve inhibition of ERK 1/2 phosphorylation, modulation of cyclin D1 and p27kip1, and antagonism of the NMDA receptor. Poor oral bioavailability limits therapeutic applications, but novel formulations and derivatization are under development to address this.

Other names
crocetin
02

Targets

GRIN2B (N-methyl-D-aspartate Receptor Subunit Combination: NR1a/NR2B)AMPK (Adenosine monophosphate–activated protein kinase)CCND1 (Cyclin D1)CDKN1B (Transmembrane emp24 domain-containing protein 7)ICAM2 (ICAM-2)MAPK3 (Mitogen-activated protein kinase 1)NF-κBOLR1 (Lectin-like oxidized LDL receptor-1)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)

Beyond the preview

Go deeper on crocetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on crocetin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call